The German chemical giant BASF is moving ahead with its plan to spin off its farming chemicals business. That is a concrete step - not just a promise.
Deutsche Bank and Goldman Sachs are already working with BASF on carving the unit out from the rest of the company. Now BASF wants other banks to line up too, which usually means the deal is getting serious.
A company spokesperson confirmed the move, saying "this is a step on the way to IPO readiness, which is targeted by mid-2027." The division - called Agricultural Solutions - makes herbicides, fungicides, and other products farmers use to protect crops. It is a big business, and the IPO could make it one of the larger European stock listings in recent years.
To put it in context, that is roughly the same size as the entire market value of companies like Bayer or Corteva, which also focus on agriculture. BASF itself is worth about €45 billion, so this unit would represent nearly half of the parent company's total value.
Get the market news that matters in a five-minute read with Market Briefs, our free daily newsletter
The listing is expected on the Frankfurt Stock Exchange, though BASF had also considered a US listing earlier. Keeping the Frankfurt option suggests the company wants to stay close to its home market, at least for now.
The bottom line: A major IPO like this does not happen in a vacuum. When a €20 billion company hits the market, it can shift how money flows into the agriculture sector. Other ag stocks - from seed companies to fertilizer makers - may see some of that attention too.
But the real story here is about timing. That is a long runway.
Between now and then, plenty can change - interest rates, crop prices, regulations. The company is doing the hard work now so that when the window opens, it is ready to go public.
For investors, the lesson is patient: keep an eye on how the carve-out progresses. If BASF manages to get this done on schedule, it could be one of the more interesting European IPOs in years. If it hits snags, the delay tells you something about the market's appetite for ag stocks.
Either way, you do not need to own BASF stock to care. Big spin-offs often create ripples that touch other holdings in your portfolio, especially if you own any chemical or agriculture funds. Watch how the banks line up. That will tell you a lot about who thinks this deal is worth fighting for.
Join Market Briefs, our free daily newsletter, for a quick daily rundown of the markets
